Thyroidectomy without radioiodine in patients with low-risk thyroid cancer
S Leboulleux, C Bournaud, CN Chougnet… - … England Journal of …, 2022 - Mass Medical Soc
Background In patients with low-risk differentiated thyroid cancer undergoing thyroidectomy,
the postoperative administration of radioiodine (iodine-131) is controversial in the absence …
the postoperative administration of radioiodine (iodine-131) is controversial in the absence …
[PDF][PDF] Thyroidectomy without radioiodine in patients with low-risk thyroid cancer
S Leboulleux, C Bournaud, CN Chougnet - N. Engl. J. Med, 2022 - journals.viamedica.pl
Metody. W badaniu III fazy chorych niekwalifikujących się do intensywnej indukcyjnej
chemioterapii przydzielono losowo do stosowania doustnego iwosydenibu (500 mg raz na …
chemioterapii przydzielono losowo do stosowania doustnego iwosydenibu (500 mg raz na …
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer.
S Leboulleux, C Bournaud, CN Chougnet… - The New England …, 2022 - europepmc.org
Background In patients with low-risk differentiated thyroid cancer undergoing thyroidectomy,
the postoperative administration of radioiodine (iodine-131) is controversial in the absence …
the postoperative administration of radioiodine (iodine-131) is controversial in the absence …
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid Cancer
S Leboulleux, C Bournaud… - The New England …, 2022 - pubmed.ncbi.nlm.nih.gov
Background In patients with low-risk differentiated thyroid cancer undergoing thyroidectomy,
the postoperative administration of radioiodine (iodine-131) is controversial in the absence …
the postoperative administration of radioiodine (iodine-131) is controversial in the absence …